Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
    • Sjögren’s Disease
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Neutralizing IL-23 and Its Targets May Improve Ankylosing Spondylitis

Lara C. Pullen, PhD  |  August 30, 2012

Researchers have identified a unique population of entheseal resident cells that can be activated by interleukin 23 (IL-23). This finding may be key to understanding how dysregulation of IL-23 results in precise inflammation of the entheses.

Newly Discovered Molecule Modulates Cartilage Repair

Lara C. Pullen, PhD  |  August 29, 2012

Chondrocytes play an important role in cartilage repair as well as symptom relief. Research published in Science provides insights into the role of stem cell–based therapies in the promotion of chondrogenesis and cartilage repair.

ACA Upheld: What Does This Mean for Rheumatology?

Richard Quinn  |  August 17, 2012

What does the Supreme Court decision to uphold the Affordable Care Act mean for rheumatologists?

Gene Mutation Could Cause Gut Microbe Changes that Lead to RA

David Holzman  |  July 31, 2012

A new study suggests that a small abnormality in an immunity gene can alter the gut flora in a way that induces development of rheumatoid arthritis.

Letter: Skepticism on Steroids in RA

Staff  |  July 24, 2012

There is not a consensus between all European rheumatologists regarding the use of steroids in RA; quite a few share your skepticism.

New Lupus Insight Prize Aims to Advance Lupus Research

Dawn Antoline  |  July 2, 2012

The Lupus Insight Prize will provide $200,000 to one researcher to help fund a project dedicated to furthering understanding of the genetic, environmental, molecular, immunologic, or cellular aspects of lupus or its treatment.

Medscape Surveys Show Rheumatologists Happiest at Home but Concerned about Pay and Other Professional Issues

Kurt Ullman  |  July 2, 2012

The Medscape 2012 Physician Lifestyle and Compensation Reports shows that rheumatologists are increasingly dissatisfied with pay but are the happiest group of physicians in the survey.

Researcher Reflects on the Development of the Disease Activity Score

Staff  |  May 8, 2012

Listen to Désirée van der Heijde, MD, PhD, reflect on working with Piet van Riel, MD, PhD to develop this method to measure disease activity outcome.

Lupus Survey Finds Gaps in Communication

Alexandra Schultz  |  May 2, 2012

More than 90% of systemic lupus erythematosus (SLE) patients experience a communication gap with their family and with their care team, according to a recent survey conducted by GfK Roper North America. The survey found that many SLE patients downplay their symptoms to friends, family, and even their doctors.

First World Autoimmune Arthritis Day Will Link People in “Virtual Convention”

Kurt Ullman  |  May 1, 2012

World Autoimmune Arthritis Day will be held from 6 a.m. EDT on May 19 through 5 a.m. EDT on May 21. It is a worldwide virtual convention focusing on autoimmune arthritis. Through the Internet, patients and supporters will be able to learn more about their disease while interacting with others from many countries.

  • « Previous Page
  • 1
  • …
  • 317
  • 318
  • 319
  • 320
  • 321
  • 322
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences